Li Ka Shing Foundation donates Asia's first cutting-edge, non-invasive device for treatment of liver cancer to city's oldest university Hong Kong liver cancer patients can receive a painless ...

data-text=Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotri Tuesday, 02 January 2024 12:17 GMT عربي ...

HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison™ Histotripsy System, announced today the company’s initial partnership in As ...

L'Università di Hong Kong e la Chinese University di Hong Kong avvieranno programmi innovativi di istotripsia per i tumori epatici MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, (www.histosonics.com ...

NHS patents will be the first in Europe outside a trial setting to have access to a liver cancer treatment described as "cutting-edge and non-invasive". Addenbrooke's Hospital in Cambridge will start ...

Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) are purchasing and donating two Histotripsy Systems to the National Cancer Centre Si. Tuesday, 02 January 2024 12:17 GMT. ...

MINNEAPOLIS, August 28, 2024--HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison™ Histotripsy System, announced today the company’s initial partnership in Asia ...

Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) are purchasing and donating two Histotripsy Systems to the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, ...

Li Ka Shing Foundation believes in philanthropy with societal impact. Since 1980, we have been helping to reform education and further medical research. To date, Mr Li Ka-shing has invested over HK$30 ...

Li Ka Shing Foundation believes in philanthropy with societal impact. Since 1980, we have been helping to reform education and further medical research. To date, Mr Li Ka-shing has invested over HK$30 ...